Comparison of SCH-12679 and Thioridazine in Aggressive Mental Retardates

Albert J.M. , Langlois Y. , Gravel L. : Etude pilote du SCH-12679 chez les arriérés mentaux profonds présentant des troubles graves du comportement. Union Méd Can, 104: 904–909, 1975.

Albert J.M. , Elie R. , Cooper S.F. , Clermont A. , and Langlois Y. : Efficacy of SCH-12679 in the management of aggressive mental retardates. Curr Ther Res, 21: 786–795, 1977.

Cooper S.F. , Elie R. , Albert J.M. , Gravel G.B. , Langlois Y. : Gas-liquid Chromatographic method for the measurement of plasma levels of d-7,8-dimethoxy-3-methylphenyl-2,3,4,5-tetrahydro-1H-3-benzazepine acid maleate (SCH-12679) and its major metabolites in aggressive mental retardates. J Chromatogr, 163: 47–56, 1979.

D'Hollander L. , Fontaine P.J. : Clinical evaluation of the effect of dixyrazine on behavior disturbances in children treated in a medicopedagogical institution. Neurol Psychiat Belg, 67: 5–35, 1967.

Itil T.M. , Stock M.J. , Duffy A.D. , Esquenazi A. , Saletu B. , Han T.H. : Therapeutic trials and EEG investigations with SCH-12679 in behaviorally disturbed adolescents. Curr Ther Res, 14: 136–150, 1972.

Keskiner A. , Itil T.M. , Han T.H. , Saletu B. , Hsu W. : Clinical toxicological and electroencephalographic study with SCH-12679 in chronic schizophrenics. Curr Ther Res, 13: 714–725, 1971.

Kurland A.A. , Goldberg J.B. : Piperacetazine (Quide) in the management of behavioral disorders in mildly retarded institutionalized boys. Curr Ther Res, 12: 798–804, 1970.

Rajotte P. , Giard N. , and Tetreault L. : A controlled trial of propericiazine and chlorpromazine in “behaviour disorders.” Curr Ther Res, 8: 166–174, 1966.

Ucer E. , and Kreger K.C. : A double-blind study comparing haloperidol and thioridazine in emotionally disturbed, mentally retarded children. Curr Ther Res, 11: 278–283, 1969.